Clinical Trial Update: Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

The document notes the completion of an early-phase study evaluating PSMA-based PET imaging as a biomarker in advanced prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Advanced Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED